Hematological Oncology

Cover image for Vol. 35 Issue 2

Edited By: Francesco Bertoni

Impact Factor: 3.118

ISI Journal Citation Reports © Ranking: 2016: 28/70 (Hematology); 103/217 (Oncology)

Online ISSN: 1099-1069

Recently Published Issues

See all

  • Current Issue:June 2017

    Volume 35, Issue Supplement S2

    14th International Conference on Malignant Lymphom...

  • June 2017

    Volume 35, Issue 2

  • June 2017

    Volume 35, Issue Supplement S1

    14th International Conference on Malignant Lymphom...

  • March 2017

    Volume 35, Issue 1

  • December 2016

    Volume 34, Issue 4

Sign Up Today!

Get E-alerts from HON

Save time and let the research come to you

For a fast and convenient route to the most recently published articles in the Hematological Oncology, you can register for email alerts. Wiley Online Library email alerts link you directly to the abstracts of newly published papers.

Setting up e-alerts is as easy as 1, 2, 3...

Recently Published Articles

  1. Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry

    Irene Biasoli, Nelson Castro, Marcia Delamain, Talita Silveira, James Farley, Belinda Pinto Simões, Cristiana Solza, Monica Praxedes, Otávio Baiocchi, Rafael Gaiolla, Fernanda Franceschi, Caroline Bonamin Sola, Carla Boquimpani, Nelma Clementino, Guilherme Perini, Kátia Pagnano, Giovanna Steffenello, Jacques Tabacof, Gilberto de Freitas Colli, Andrea Soares, Carmino de Souza, Carlos Sérgio Chiattone, Cristiane Milito, José Carlos Morais and Nelson Spector

    Version of Record online: 23 JUN 2017 | DOI: 10.1002/hon.2450

  2. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma

    Brady E. Beltran, Pilar Quiñones, Domingo Morales, Jose M. Malaga, Julio C. Chavez, Eduardo M. Sotomayor and Jorge J. Castillo

    Version of Record online: 22 JUN 2017 | DOI: 10.1002/hon.2449

  3. Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival

    Erel Joffe, N. Ariela Arad, Osnat Bairey, Riva Fineman, Rosa Ruchlemer, Naomi Rahimi-Levene, Lev Shvidel, Uri Greenbaum, Ariel Aviv, Tamar Tadmor, Andrei Braester, Neta Goldschmidt, Aaron Polliack and Yair Herishanu

    Version of Record online: 22 JUN 2017 | DOI: 10.1002/hon.2444

  4. Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma

    Shang-Yi Huang, Cheng-Shyong Chang, Ta-Chih Liu, Po-Nan Wang, Su-Peng Yeh, Ching-Liang Ho, Ming-Chung Kuo, Hsuan-Yu Lin, Jan de Jong, Jia-Yi Chen and Ya-Wen Yang

    Version of Record online: 19 JUN 2017 | DOI: 10.1002/hon.2432

  5. Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with “standard” immunochemotherapy: A large retrospective study from 4 institutions

    Stefania Gobba, Alden A. Moccia, Wiebke Gulden-Sala, Annarita Conconi, Stefan Diem, Luciano Cascione, Gloria Iacoboni, Gloria Margiotta-Casaluci, Kathrin Aprile von Hohenstaufen, Anastasios Stathis, Felicitas Hitz, Graziella Pinotti, Gianluca Gaidano and Emanuele Zucca

    Version of Record online: 16 JUN 2017 | DOI: 10.1002/hon.2447